I think that the pricing of the card had to do more with when it was launched than anything else. AMD and nVidia had to tread carefully with pricing because, at that time, scalpers would've just bought them up if the price was too low and sold them for (probably) what AMD did sell them for. The consumers would've lost either way and AMD probably decided that the money was better in their pockets than in the pockets of the scalpers and I can't really say that I disagree with that position. The more money AMD gets, the more R&D they can do to make better products for us consumers while the scalpers would probably spend it all on hookers and blow! 🤣
That's a fact, no doubt! 👍
I think the problem there is that I don't think it would sell well enough in the US, Canadian and European markets. I think setups like that are probably more applicable to OEMs like Dell or HP and since both of those companies are essentially in Intel's back pocket, a product like that might flop. Sure, there might be a few DIYers who would buy it but I'm not convinced that there would be enough that AMD wouldn't lose their shirts on a product like that.
Biostar sells a lot to Asian (specifically Chinese) OEMs and FM2-based APUs would've been attractive to them but not really anyone else (because, Intel). I'm guessing that it was only Biostar who did it because I hadn't seen anything like that from the big four (ASRock, ASUS, Gigabyte and MSi).
My guess would be that it's because the big four don't have that strong relationship with Chinese OEMs that Biostar does. Biostar isn't exactly a hot seller around the world like the big four yet they've been in business for over 30 years. That tells me their bread-and-butter is probably OEMs that are Asia-specific because it's the only way that I can imagine they're able to stay in business and fly under everyone's radar like they do.